Diffuse large B-cell lymphoma with cutaneous involvement in a patient with xeroderma pigmentosum type C.
作者信息
Laughter Melissa R, Tegla Cosmin A, Pawar Shashi, Moshiri Ata S, Orlow Seth J
机构信息
Ronald O Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York.
Division of Hematology and Medical Oncology, NYU Langone Health, New York, New York.
出版信息
JAAD Case Rep. 2024 May 7;49:28-31. doi: 10.1016/j.jdcr.2024.04.039. eCollection 2024 Jul.
Abstract
摘要
相似文献
1
Diffuse large B-cell lymphoma with cutaneous involvement in a patient with xeroderma pigmentosum type C.
JAAD Case Rep. 2024 May 7;49:28-31. doi: 10.1016/j.jdcr.2024.04.039. eCollection 2024 Jul.
2
Germline and somatic mutations of the INK4a-ARF gene in a xeroderma pigmentosum group C patient.
J Invest Dermatol. 2002 Dec;119(6):1355-60. doi: 10.1046/j.1523-1747.2002.19603.x.
3
Severe cisplatin-induced renal toxicity in a patient with xeroderma pigmentosum.
J Oncol Pharm Pract. 2022 Mar;28(2):466-470. doi: 10.1177/10781552211038246. Epub 2021 Oct 14.
4
Oxidative damage induced genotoxic effects in human fibroblasts from Xeroderma Pigmentosum group A patients.
Int J Biochem Cell Biol. 2008;40(11):2583-95. doi: 10.1016/j.biocel.2008.05.009. Epub 2008 May 21.
5
Impaired ultraviolet-B-induced cytokine induction in xeroderma pigmentosum fibroblasts.
J Invest Dermatol. 2001 Nov;117(5):1151-5. doi: 10.1046/j.0022-202x.2001.01525.x.
6
[A whole family affected by xeroderma pigmentosum: clinical and genetic particularities].
Ann Dermatol Venereol. 2003 Jan;130(1 Pt 1):31-6.
7
Role of Xeroderma pigmentosum D (XPD) protein in genome maintenance in human cells under oxidative stress.
Mutat Res Genet Toxicol Environ Mutagen. 2022 Apr-May;876-877:503444. doi: 10.1016/j.mrgentox.2022.503444. Epub 2022 Jan 15.
8
Ultraviolet radiation-induced suppression of natural killer cell activity is enhanced in xeroderma pigmentosum group A (XPA) model mice.
J Invest Dermatol. 1999 Jun;112(6):965-70. doi: 10.1046/j.1523-1747.1999.00597.x.
9
Hypersensitivity of xeroderma pigmentosum cells to dietary carcinogens.
Mutat Res. 1985 Jan-Mar;145(1-2):89-94. doi: 10.1016/0167-8817(85)90045-8.
10
Reinvestigation of the classification of five cell strains of xeroderma pigmentosum group E with reclassification of three of them.
J Invest Dermatol. 2000 May;114(5):1022-9. doi: 10.1046/j.1523-1747.2000.00952.x.
本文引用的文献
1
Xeroderma pigmentosum: an updated review.
Drugs Context. 2022 Apr 25;11. doi: 10.7573/dic.2022-2-5. eCollection 2022.
2
Severe cisplatin-induced renal toxicity in a patient with xeroderma pigmentosum.
J Oncol Pharm Pract. 2022 Mar;28(2):466-470. doi: 10.1177/10781552211038246. Epub 2021 Oct 14.
3
XPC deficiency increases risk of hematologic malignancies through mutator phenotype and characteristic mutational signature.
Nat Commun. 2020 Nov 17;11(1):5834. doi: 10.1038/s41467-020-19633-9.
4
and Translocation in B-cell Non-Hodgkin Lymphoma Cases.
J Cancer. 2020 Jan 1;11(1):190-198. doi: 10.7150/jca.36954. eCollection 2020.
5
Unusual intraoral cancer with unexpected outcome in a patient with xeroderma pigmentosum: An alert for antineoplastic treatment.
Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Jan;129(1):e1-e11. doi: 10.1016/j.oooo.2019.09.017. Epub 2019 Oct 12.
6
Predisposition to hematologic malignancies in patients with xeroderma pigmentosum.
Haematologica. 2020 Apr;105(4):e144-e146. doi: 10.3324/haematol.2019.223370. Epub 2019 Aug 22.
7
Familial predisposition to TP53/complex karyotype MDS and leukemia in DNA repair-deficient xeroderma pigmentosum.
Blood. 2019 Jun 20;133(25):2718-2724. doi: 10.1182/blood-2019-01-895698. Epub 2019 Mar 26.
8
Alert Regarding Cisplatin-induced Severe Adverse Events in Cancer Patients with Xeroderma Pigmentosum.
Intern Med. 2017;56(8):979-982. doi: 10.2169/internalmedicine.56.7866. Epub 2017 Apr 15.
9
Oxidative DNA damage and nucleotide excision repair.
Antioxid Redox Signal. 2013 Jun 20;18(18):2409-19. doi: 10.1089/ars.2012.5036. Epub 2012 Dec 7.
10
Acute megakaryoblastic leukemia in a patient with xeroderma pigmentosum: discussion of pathophysiological, prognostic, and toxicological aspects.
Acta Haematol. 2013;129(2):121-5. doi: 10.1159/000342897. Epub 2012 Nov 28.
Zotero 插件